Aratana Therapeutics And Atopix Complete Global Licensing Agreement For Development And Commercialization Of Novel Atopic Dermatitis Program
October 13, 2014 at 08:07 AM EDT
Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative ...
